Literature DB >> 10417562

Human pancreatic carcinoma cells are sensitive to photodynamic therapy in vitro and in vivo.

A Hajri1, S Coffy, F Vallat, S Evrard, J Marescaux, M Aprahamian.   

Abstract

BACKGROUND: The aim of this study was to assess the efficiency of photodynamic therapy (PDT) on human pancreatic cancer cells in vitro and in an animal model.
METHODS: Human pancreatic tumour cell lines were submitted to PDT with pheophorbide a (Ph a), a chlorophyll derivative, in culture and after grafting into athymic mice. Ph a was tested in culture (10-10-10-5 mol/l) with a 5-J/cm2 energy treatment and on tumour-bearing Nude mice (30 mg/kg intraperitoneally) with a 100-J/cm2 PDT session. The effect of PDT was assessed in vitro using proliferative, apoptotic and clonogenic tests and in vivo on tumour growth and on the induction of tumour necrosis.
RESULTS: PDT inhibited tumour cell growth in culture by affecting DNA integrity. This tumour cell photodamage started at low concentration (10-7 mol/l) as corroborated by clonogenic and tumour growth tests. A strong necrosis was achieved in vivo with a single PDT session.
CONCLUSION: PDT destroyed human pancreatic carcinoma after low photosensitizer supply and weak energy application. It exerted this tumoricidal effect via apoptosis induction with a gentle protocol, and apoptosis and/or necrosis with a stronger protocol.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417562     DOI: 10.1046/j.1365-2168.1999.01132.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

1.  Effect of Photofrin-mediated photocytotoxicity on a panel of human pancreatic cancer cells.

Authors:  Luo-Wei Wang; Zheng Huang; Han Lin; Zhao-Shen Li; Fred Hetzel; Bolin Liu Md
Journal:  Photodiagnosis Photodyn Ther       Date:  2013-01-30       Impact factor: 3.631

Review 2.  Photodynamic therapy for pancreatic and biliary tract carcinoma.

Authors:  Lakshmana Ayaru; Stephen G Bown; Stephen P Pereira
Journal:  Int J Gastrointest Cancer       Date:  2005

3.  Pheophorbide a-Mediated Photodynamic Therapy Triggers HLA Class I-Restricted Antigen Presentation in Human Hepatocellular Carcinoma.

Authors:  Patrick Ming-Kuen Tang; Ngoc-Ha Bui-Xuan; Chun-Kwok Wong; Wing-Ping Fong; Kwok-Pui Fung
Journal:  Transl Oncol       Date:  2010-04       Impact factor: 4.243

4.  Simultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer.

Authors:  Shifalika Tangutoori; Bryan Q Spring; Zhiming Mai; Akilan Palanisami; Lawrence B Mensah; Tayyaba Hasan
Journal:  Nanomedicine       Date:  2015-09-25       Impact factor: 5.307

Review 5.  Role of endoscopic ultrasound in diagnosis and therapy of pancreatic adenocarcinoma.

Authors:  Joseph Boujaoude
Journal:  World J Gastroenterol       Date:  2007-07-21       Impact factor: 5.742

6.  Photodynamic therapy inhibits P-glycoprotein mediated multidrug resistance via JNK activation in human hepatocellular carcinoma using the photosensitizer pheophorbide a.

Authors:  Patrick Ming-Kuen Tang; Dong-Mei Zhang; Ngoc-Ha Bui Xuan; Stephen Kwok-Wing Tsui; Mary Miu-Yee Waye; Siu-Kai Kong; Wing-Ping Fong; Kwok-Pui Fung
Journal:  Mol Cancer       Date:  2009-07-31       Impact factor: 27.401

7.  Selectivity of the photosensitiser Tookad for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model.

Authors:  F Borle; A Radu; C Fontolliet; H van den Bergh; P Monnier; G Wagnières
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640

Review 8.  Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer Agents.

Authors:  Josephine S Modica-Napolitano; Volkmar Weissig
Journal:  Int J Mol Sci       Date:  2015-07-29       Impact factor: 5.923

9.  The sensitivity of cancer cells to pheophorbide a-based photodynamic therapy is enhanced by Nrf2 silencing.

Authors:  Bo-hyun Choi; In-geun Ryoo; Han Chang Kang; Mi-Kyoung Kwak
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

Review 10.  Photosensitizers in prostate cancer therapy.

Authors:  Taher Gheewala; Troy Skwor; Gnanasekar Munirathinam
Journal:  Oncotarget       Date:  2017-05-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.